People with chronic liver disease have dramatic changes to the types and functions of bacteria in the gut and mouth, a new study has revealed.

2). New approaches that improve response rates are therefore desperately needed. Figure 2: Sustained virological response rates with treatments for hepatitis C. As with HIV drug development ...

The objectives of this review are to highlight the improvements that have been made in the current treatment of autoimmune hepatitis and to indicate the progress toward new therapies that justify ...

The publication of the WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection coincides with a wave of new oral treatments for hepatitis, which promise to be ...

Autoimmune hepatitis (AIH) is a chronic, progressive inflammatory liver disease caused by autoimmune reactions, with an unknown etiology. If left untreated, it can progress to cirrhosis, liver failure ...

Treatment for acute hepatitis B usually ... immunosuppressant medications so your body doesn’t reject the new healthy liver. Hepatitis B is a potentially severe disease that stems from infection ...

Between February 2019 and June 2024, around 6400 New Zealanders with hepatitis C had received a course of the hepatitis C treatment Maviret through the public health system. More than 100 New ...

This loss is a potential indicator of the treatment's effectiveness ... update and sharing progress on its clinical programs for Hepatitis B (HBV). The update was led by Interim President and ...

A new risk score for HCC risk in non-viral hepatitis or cirrhosis patients improves detection by 22.9%. The model uses FIB-4, ...